The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 12, 2022

Filed:

Mar. 11, 2015
Applicant:

D&d Pharmatech Inc., Seongnam-Si, KR;

Inventors:

Kang Choon Lee, Seoul, KR;

Ha Na Eom, Gyeonggi-do, KR;

Assignee:

D&D PHARMATECH INC., Seongnam-si, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/705 (2006.01); A61K 38/17 (2006.01); A61K 45/06 (2006.01); A61K 39/395 (2006.01); A61K 47/60 (2017.01);
U.S. Cl.
CPC ...
C07K 14/70575 (2013.01); A61K 38/177 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61K 47/60 (2017.08); C07K 2319/00 (2013.01); C07K 2319/73 (2013.01);
Abstract

Methods of treating an autoimmune disease such as rheumatoid arthritis, methods of increasing apoptosis of pro-inflammatory immune cells or synoviocytes, methods of increasing the quantity of the anti-inflammatory regulatory T cells, and methods of slowing the progression of inflammation in a subject include systemically administering to the subject a pharmaceutical composition including an effective amount of a TRAIL-conjugate. Preferably, the TRAIL-conjugate is effective for at least 3 days, more preferably at least 7 days, without being part of a nanocomplex that modulates the circulation half-life or release kinetics of the TRAIL-conjugate. Combination therapies including administering a second active agent, most preferably a TNF-α inhibitor, as well as pharmaceutical composition dosage units including a TRAIL-conjugate and a TNF-α inhibitor in an effective amount for a single once weekly dose for treatment of rheumatoid arthritis are also provided.


Find Patent Forward Citations

Loading…